At the end of 2012, we updated our coverage on the penny stock of Generex Biotechnology Corp. (GNBT) and the devastating slide the shares had been on all year. With hopes and expectations that someone would come along and drop some much needed cash into the biotech focused on treating and curing breast cancer, the news of an investor conference call scheduled for 10am today was enough ...
January is, and has been, Biotech month. With conferences in San Francisco wrapping up just in time for the AFC divisional playoff game this weekend, news flow will begin to hit the street of deals and JVA in the coming days and weeks. One penny stock many traders are speculating will have some positive momentum is that of
Continue Reading →
11
Share
JAN
While 2012 has been a banner year for a number of biotech stocks and their shareholders, one company which was not as fortunate has traders studying them in hopes they may have finally reached the oversold level. The year started out great for Generex Biotechnology Corp. (GNBT) with their proprietary technology to ward of tumors in breast cancer patients gaining rave reviews. However, since the shares ...
VIP members again saw the penny stock picking power Tuesday when we spoke in detail of the bullish running about to occur on BG Medicine Inc. (BGMD). When we scanned for pre-market activity and news, and while everyone was panicking over the cluster bombs dropped on SVEN and PBCW from Monday, ...
Known for being the worst performing low-priced stocks listed on the Nasdaq at times, the penny stock of Cleveland BioLabs Inc. (CBLI) returned into Wall Street’s good graces last week. A familiar name to many Wall Street analysts, CBLI stock received to positive rating s this week and price targets which have upsides of 110% and 180% respectively. Considering that shares ...
Yesterday’s higher than usual volume on the penny stock of Immunovative, Inc. (IMUN) proved to many that sellers aren’t bailing out on the patent squatters. With news of a 12th patent issued to Immunovative Therapies Ltd. with whom the Company has an exclusive worldwide license with, the closer wither of the two cancer drugs get, the more
Continue Reading →
27
Share
NOV
This week, we begin with a penny stock alert issued on a biopharmaceutical, development stage company we like (a lot) — Anavex Life Sciences Corp. (AVXL). The company has a lead drug candidate, ANAVEX 2-73, which scored much better Phase I results than many of the high-profile failures in the Alzheimer’s disease space. Considering that the upside potential for
Continue Reading →
5
Share
NOV
Sometimes a changing of the guard by bringing on board persons who have the same vision of a Company is needed in order to stimulate growth and capitalize on the mission statement. Viropro Inc. (VPRO) did just that after Friday’s trading session when they reported three new replacement members to their Board of Directors, all of which are well seasoned. Couple the change with the ...
If you’ve been trading penny stocks for more than one month, you would have to look at the chart of the last month on TNI BioTech Inc. (TNIB) and say OMFG! Although the pink sheet listed, recently massively reverse split, less than $400 in the bank biotech just began trading 3 months ago, TNIB ...
Shares of biotechnology focused CytoCore, Inc. (CYOE) will be on high alert Thursday as the uncompensated pick of the most infamous 5 minute gainer. CYOE stock traded less dollar volume on Wednesday than it costs to take a Greyhound bus from Miami to Washington D.C. Today will not be the same and you can see why below when the question ...
